Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
World Journal of Gastrointestinal Oncology|August 7, 2013
Chemotherapy for cholangiocarcinoma: An updateNatalia Ramírez-Merino, Santiago Ponce Aix, Hernán Cortés-FunesArchives of Medical Research|December 2, 2022
Molecular Targeted Therapy in Oncology Focusing on DNA Repair MechanismsCarlos Garzón-Hernández, Natalia Ramírez-Merino, María Cruz Martín SoberonNature Reviews. Clinical Oncology|December 15, 2010
HER2 and hormone receptor-positive breast cancer--blocking the right targetJavier Cortés, Cristina Saura, Meritxell Bellet, et al.Neoplasia (New York, N.Y.)|May 19, 2026
Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancerMelani Luque, Miriam Morales-Gallego, Marta Sanz-Álvarez, et al.International Journal of Molecular Sciences|January 11, 2024
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell LinesMarta Sanz-Álvarez, Melani Luque, Miriam Morales-Gallego, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 17, 2026
Bone health in patients with cancer: a SEOM-SEIOMM consensus review of risk factors, assessment strategies, and management approachesCarmen Beato-Zambrano, Xavier Nogues, Natalia Ramírez-Merino, et al.ESC Heart Failure|February 2, 2022
Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parametersBelén Díaz-Antón, Rodrigo Madurga, Blanca Zorita, et al.Pageof 1